Title: Global Pharmaceutical Sales Force
1Global Pharmaceutical Sales ForceDeployment
AnalyzerEurope, India, Japan, Latin Americaand
the United States
2GLOBAL PHARMACEUTICALSALES FORCEDEPLOYMENT
ANALYZER CAPABILITIES
1
3About PharmaForce International
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT
ANALYZER CAPABILITIES
- Specialists in multi-client (syndicated) and
proprietary sales, marketing and medical
benchmarking and market research for the
pharmaceutical and biotech industries - Global leaders in identifying everything and
anything that pharmaceutical companies want to
know about the operations of their competitors
and perspectives of their customers - Multi-lingual staff with direct experience in the
pharmaceutical industry and business intelligence - Hundreds of years of combined industry experience
as District Managers, Product Managers, Medical
Information Specialists, Market Research
Directors, Training Managers and Country Business
Unit Directors
2
4Field-Tested Primary Source Research Approach
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT
ANALYZER CAPABILITIES
- More than 90 of the information for any project
is derived from one-on-one interviews with
individuals in the industry, including current
and former employees of the target organizations - Interviewers draw upon their knowledge and
personal experiences in the industry to form a
common bond with interview targets and engage in
peer-to-peer discussions about topics of common
interest - Supplemented with exhaustive searches of all
relevant electronic and printed databases,
including PharmaForces proprietary databases
developed over the past decade - Database of qualified contacts in the
pharmaceutical industry exceeds 45,000 - Includes personnel in almost every sales and
marketing function from sales representatives to
senior management - Systematic, ongoing process to add new contacts
3
5Field-Tested Primary Source Research Approach
(contd)
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT
ANALYZER CAPABILITIES
- Typically, 25 of interviewees participate
willingly, while another 25 refuse to
participate - Strong interviewing skills come into play with
the middle 50 as key partial pieces of data are
culled from their limited responses - Ability to trade data on previously-researched
companies dramatically increases the level of
cooperation - One-on-one discussions with multiple
knowledgeable sources result in verification of
data - Outliers are quickly identified and assimilated
through more interviews
4
6Field-Tested Primary Source Research Approach
(contd)
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT
ANALYZER CAPABILITIES
- Triangulation of data from contacts who are
customers, suppliers and target company employees
results in multiple confirmations of findings
from all possible perspectives - Previous research experience on the topics allows
for the widest possible knowledge base of the
target deliverables and key resources
5
7About the Global Deployment Analyzer
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT
ANALYZER CAPABILITIES
- Based on client requests for timely and accurate
deployment and marketed product information,
PharmaForce International developed the Global
Pharmaceutical Sales Force Deployment Analyzer - Powerful web-based database program that covers
the deployment of leading pharmaceutical
companies sales forces in the United States,
Europe, India, Japan and selected Latin American
countries - Easy-to-use database contains up-to-date
information on leading companies in Europe,
India, Japan , Argentina, Brazil , Mexico and the
United States - Continuously-updated database
- As PharmaForce receives new or revised data on
each of the target companies, the new data will
be immediately added to the database - No waiting for the next quarterly or yearly
installment
6
8About the Global Deployment Analyzer (contd)
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT
ANALYZER CAPABILITIES
- Available database programs
- European Deployment Analyzer database
- Introduced in 2003
- Information about 25 leading pharmaceutical
companies sales forces - Japan Deployment Analyzer database
- Launched in 2009
- Information about 26 leading pharmaceutical
companies sales forces - U.S. Deployment Analyzer database
- Introduced in 2008
- Information about over 60 leading pharmaceutical
companies sales forces
7
9About the Global Deployment Analyzer (contd)
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT
ANALYZER CAPABILITIES
- India Deployment Analyzer database
- Introduced in 2012
- Information about 12 leading pharmaceutical
companies sales forces - Latin America Deployment Analyzer database
- Introduced in 2012
- Information about 13 companies in Argentina,
Brazil and Mexico
8
10About the Global Deployment Analyzer (contd)
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT
ANALYZER CAPABILITIES
- Easy-to-use web-based database enables users to
generate custom reports based upon any
combination of the following variables - Brand
- Therapeutic area
- Company
- Country
- Time period
9
11About the Global Deployment Analyzer (contd)
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT
ANALYZER CAPABILITIES
- Data available in the Deployment Analyzer
includes - Total number of company Sales Representatives
deployed by sales group - Primary Care
- Specialty/Hospital
- Number of Sales Representatives by therapeutic
area - Number of Sales Representatives (Full-Time
Equivalents/FTEs) supporting individual brands - Based on relative effort reported by company
personnel in interviews - Product priorities by each
- Sales group
- Sales force (U.S. only)
- Therapeutic area
10
12About the Global Deployment Analyzer (contd)
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT
ANALYZER CAPABILITIES
- Average salaries and bonuses
- Data available in the U.S. and Japan Deployment
Analyzers also includes - Total number of District Managers, Regional
Managers and other sales management by
group/division as defined by the target company - Sales group organizational structures
- Call Reach Frequency Analysis
11
13Comprehensive List of Therapeutic Areas Covered
in the Database
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT
ANALYZER CAPABILITIES
- Anti-Infectives (includes antibiotics,
anti-fungals anti-virals) - Cardiovascular
- CNS, Pain and Anesthesia
- Dermatology
- Endocrinology and Metabolic Disorders
- Gastrointestinal
- Gynecology/Womens Health
- Nephrology and Transplantation
- Oncology and Hematology
- Ophthalmology
- Respiratory and Allergy
- Rheumatology, Bone and Inflammation
- Urology
- Vaccines
- Other
12
14EUROPE DEPLOYMENT ANALYZER
13
1510 Target Countries
EUROPE DEPLOYMENT ANALYZER
- Austria
- Belgium
- France
- Germany
- Italy
- Netherlands
- Spain
- Sweden
- Switzerland
- United Kingdom
14
16Target Companies
EUROPE DEPLOYMENT ANALYZER
- AbbVie (incl. former Solvay)
- Amgen
- Astellas
- AstraZeneca
- Bayer
- Biogen Idec
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Celgene
- Daiichi-Sankyo
- Eisai
- Eli Lilly
- GlaxoSmithKline
- Janssen
- Lundbeck
- Merck Serono
- Merck Sharp Dohme (incl. former
Schering-Plough) - Novartis
- Novo Nordisk
- Pfizer
- Roche
- Sanofi (incl. former Genzyme)
- Takeda (incl. former Nycomed)
- Teva (incl. former Cephalon)
- UCB
15
17INDIA DEPLOYMENT ANALYZER
16
18Target Companies
INDIA DEPLOYMENT ANALYZER
- AbbVie
- Biocon
- Cipla
- Dr. Reddy Labs
- Eli Lilly
- Fresenius Kabi
- Lupin
- Mankind
- Novartis
- Pfizer
- Sanofi
- Sun
17
19JAPAN DEPLOYMENT ANALYZER
18
20Target Companies
JAPAN DEPLOYMENT ANALYZER
- AbbVie
- Astellas
- AstraZeneca
- Banyu (incl. former Schering-Plough)
- Bayer
- Bristol-Myers Squibb
- Chugai
- Daiichi-Sankyo
- Dainippon Sumitomo
- Eisai
- Eli Lilly
- GlaxoSmithKline
- Janssen
- Kyowa Hakko Kirin
- Mitsubishi Tanabe
- Nippon Boehringer Ingelheim
- Nippon Kayaku
- Novartis
- Otsuka
- Pfizer
- Sanofi
- Shionogi
- Taiho
- Taisho Toyama
- Takeda
- Yakult Honsha
19
21LATIN AMERICADEPLOYMENT ANALYZER
20
22Target Companies
LATIN AMERICA DEPLOYMENT ANALYZER
- AstraZeneca
- Bayer
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Eli Lilly
- EMD Serono
- Genentech/Roche
- GlaxoSmithKline
- Janssen
- Merck
- Novartis
- Pfizer
- Sanofi
21
23U.S. DEPLOYMENT ANALYZER
22
24Target Companies
U.S. DEPLOYMENT ANALYZER
- AbbVie
- Abbott Medical Optics
- Actavis (formerly Watson)
- Actelion
- Alcon (incl. Ciba Vision)
- Alexion
- Allergan
- Allos
- Amgen
- Astellas (incl. OSI)
- AstraZeneca
- Auxilium
- Bausch Lomb (incl. former Ista)
- Baxter
- Bayer
- Biogen Idec
- Boehringer Ingelheim
- Bristol-Myers Squibb (incl. former Amylin)
- Celgene (incl. former Abraxis Bioscience)
- Cooper Vision
- Cubist
- Daiichi-Sankyo
- Eisai
- Eli Lilly Company
- EMD Serono
- Endo (incl. former Indevus)
- Ferring
- Forest Lab
- Fougera Pharmaceutical
- Galderma
- Genentech/Roche
- Gilead
- GlaxoSmithKline (incl. former Stiefel)
- Ipsen
23
25Target Companies (contd)
U.S. DEPLOYMENT ANALYZER
- Iridex
- JJ Ophthalmics/Vistakon
- Janssen Biotech (formerly Centocor)
- Janssen Pharmaceuticals
- Meda
- Merck (incl. former Schering-Plough and Inspire)
- Merz
- Novartis
- Novo Nordisk
- Onyx Pharmaceuticals
- Otsuka
- Pfizer (incl. former Wyeth and King)
- Purdue
- Regeneron
- Sanofi (incl. former Genzyme)
- Sanofi Pasteur
- Shire
- Sunovion (formerly Sepracor)
- Spectrum (incl. former Allos)
- Synergetics
- Takeda (incl. former Millennium)
- Teva (incl. former Cephalon)
- UCB
- Valeant (incl. former Medicis and Dermik)
- ViiV Healthcare
- United Therapeutics
- Warner Chilcott
24
26DATABASE ACCESS
25
27Access to the Global Deployment Analyzer Database
DATABASE ACCESS
- Any employee of your organization globally may
access the Deployment Analyzer at any time, 24
hours a day - Accessible from any computer in the world with
Internet access - Access the Global Pharmaceutical Sales Force
Deployment Analyzer online at - http//www.pharmaforce.biz/
- Support
- When logged into the database, pausing the cursor
over a search button will activate a description
of the search function - Visit the FAQ section in the database for
questions about our terminology and methodology
26